A Study of SH3765 Tablets in Combination With Fulvestrant in Patients With HR+/HER2- Advanced Breast Cancer.
Clinical trial NCT07557004 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07557004
- Sponsor
- Nanjing Sanhome Pharmaceutical, Co., Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-09-30
- Primary completion
- 2027-06-30
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.